Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis

J Zakhour, SL Sharara, JR Hindy, SF Haddad, SS Kanj - Antibiotics, 2022 - mdpi.com
Pseudomonas aeruginosa is a pathogen often encountered in a healthcare setting. It has
consistently ranked among the most frequent pathogens seen in nosocomial infections …

Advances in antibacterial treatment of adults with high-risk febrile neutropenia

A Contejean, A Maillard, E Canouï… - Journal of …, 2023 - academic.oup.com
Background High-risk febrile neutropenia (HR-FN) is a life-threatening complication in
patients with haematological malignancies or receiving myelosuppressive chemotherapy …

Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective …

A Vena, M Schenone, S Corcione… - Journal of …, 2024 - academic.oup.com
Objectives To determine the association of adequate empirical combination therapy (AECT)
with 30-day all-cause mortality in patients with septic shock due to Pseudomonas …

Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors

C Royo-Cebrecos, J Laporte-Amargós, M Peña… - Pathogens, 2022 - mdpi.com
Objectives: To assess the clinical features and outcomes of Pseudomonas aeruginosa
bloodstream infection (PA BSI) in neutropenic patients with hematological malignancies …

High rate of inappropriate antibiotics in patients with hematologic malignancies and Pseudomonas aeruginosa bacteremia following international guideline …

M Chumbita, P Puerta-Alcalde, L Yáñez… - Microbiology …, 2023 - Am Soc Microbiol
Optimal coverage of Pseudomonas aeruginosa is challenging in febrile neutropenic patients
due to a progressive increase in antibiotic resistance worldwide. We aimed to detail current …

Effect of empiric antibiotics against Pseudomonas aeruginosa on mortality in hospitalized patients: a systematic review and meta-analysis

CJ Hunter, EA Marhoffer, JL Holleck… - Journal of …, 2024 - academic.oup.com
Background Empiric antibiotics active against Pseudomonas aeruginosa are recommended
by professional societies for certain infections and are commonly prescribed for hospitalized …

[PDF][PDF] Three-Year Evaluation of Pseudomonas aeruginosa Bacteremia in Patients Admitted to a University-Affiliated Hospital, Mashhad, Iran

AA Heydari, S Jamialahmadi… - Jundishapur Journal of …, 2022 - brieflands.com
Background: Pseudomonas aeruginosa is an opportunistic gram-negative pathogen that
can cause infection in almost any body part. Objectives: We aimed to evaluate the …

Aminoglicosídeos no século 21: Revisão e atualização, com ênfase na nefrotoxicidade

JLD Gazineo, GF Bissoli… - SAÚDE …, 2023 - revista.faculdadedinamica.com.br
Introdução: Aminoglicosídeos são antimicrobianos bactericidas que apresentam grande
atividade para bactérias gram-negativas aeróbias, o que torna esses medicamentos …

[PDF][PDF] Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy …

C Royo-Cebrecos, J Laporte-Amargós, M Peña… - 2024 - pdfs.semanticscholar.org
This large, multicenter, retrospective cohort study including onco-hematological neutropenic
patients with Pseudomonas aeruginosa bloodstream infection (PABSI) found that among …

Nuevos Desafíos En El Manejo De La Neutropenia Febril Y La Bacteriemia En Pacientes Inmunodeprimidos Con Malignidad

M Chumbita - 2024 - diposit.ub.edu
[spa] La neutropenia febril (NF) en los pacientes oncohematológicos representa uno de los
desafíos clínicos más significativos en la medicina. Del mismo modo, poblaciones …